nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—LHCGR—renal system—kidney cancer	0.0841	0.291	CbGeAlD
Cetrorelix—LHCGR—kidney—kidney cancer	0.0813	0.281	CbGeAlD
Cetrorelix—LHCGR—gonad—kidney cancer	0.0755	0.261	CbGeAlD
Cetrorelix—LHCGR—Ovarian Infertility Genes—SYNE2—kidney cancer	0.0604	0.298	CbGpPWpGaD
Cetrorelix—GNRHR—gonad—kidney cancer	0.0486	0.168	CbGeAlD
Cetrorelix—LHCGR—Ovarian Infertility Genes—EGR1—kidney cancer	0.015	0.0741	CbGpPWpGaD
Cetrorelix—Developmental delay—Capecitabine—kidney cancer	0.0145	0.0285	CcSEcCtD
Cetrorelix—Congenital anomaly—Capecitabine—kidney cancer	0.0145	0.0285	CcSEcCtD
Cetrorelix—Swelling—Temsirolimus—kidney cancer	0.0132	0.0261	CcSEcCtD
Cetrorelix—Hot flush—Pazopanib—kidney cancer	0.0118	0.0232	CcSEcCtD
Cetrorelix—Menopausal symptoms—Pazopanib—kidney cancer	0.0117	0.023	CcSEcCtD
Cetrorelix—Redness—Paclitaxel—kidney cancer	0.00995	0.0196	CcSEcCtD
Cetrorelix—Hot flush—Everolimus—kidney cancer	0.00929	0.0183	CcSEcCtD
Cetrorelix—Menopausal symptoms—Everolimus—kidney cancer	0.00921	0.0181	CcSEcCtD
Cetrorelix—LHCGR—Arf6 signaling events—MET—kidney cancer	0.00909	0.0449	CbGpPWpGaD
Cetrorelix—Injection site reaction—Gemcitabine—kidney cancer	0.00798	0.0157	CcSEcCtD
Cetrorelix—Hot flush—Sunitinib—kidney cancer	0.00776	0.0153	CcSEcCtD
Cetrorelix—Contusion—Paclitaxel—kidney cancer	0.0077	0.0152	CcSEcCtD
Cetrorelix—Menopausal symptoms—Sunitinib—kidney cancer	0.00769	0.0151	CcSEcCtD
Cetrorelix—Immune system disorder—Temsirolimus—kidney cancer	0.0073	0.0144	CcSEcCtD
Cetrorelix—Erythema—Temsirolimus—kidney cancer	0.00704	0.0139	CcSEcCtD
Cetrorelix—Injection site reaction—Paclitaxel—kidney cancer	0.00668	0.0131	CcSEcCtD
Cetrorelix—Erythema—Pazopanib—kidney cancer	0.00663	0.013	CcSEcCtD
Cetrorelix—LHCGR—Ovarian Infertility Genes—CDKN1B—kidney cancer	0.00661	0.0327	CbGpPWpGaD
Cetrorelix—Local reaction—Doxorubicin—kidney cancer	0.00642	0.0126	CcSEcCtD
Cetrorelix—Contusion—Capecitabine—kidney cancer	0.00632	0.0124	CcSEcCtD
Cetrorelix—Cough—Temsirolimus—kidney cancer	0.00614	0.0121	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.00602	0.0118	CcSEcCtD
Cetrorelix—Cough—Pazopanib—kidney cancer	0.00579	0.0114	CcSEcCtD
Cetrorelix—Anaphylactic shock—Temsirolimus—kidney cancer	0.00574	0.0113	CcSEcCtD
Cetrorelix—Swelling—Paclitaxel—kidney cancer	0.00553	0.0109	CcSEcCtD
Cetrorelix—Injection site reaction—Capecitabine—kidney cancer	0.00548	0.0108	CcSEcCtD
Cetrorelix—Immune system disorder—Everolimus—kidney cancer	0.00543	0.0107	CcSEcCtD
Cetrorelix—Redness—Doxorubicin—kidney cancer	0.00527	0.0104	CcSEcCtD
Cetrorelix—Erythema—Everolimus—kidney cancer	0.00523	0.0103	CcSEcCtD
Cetrorelix—Hot flush—Paclitaxel—kidney cancer	0.00521	0.0103	CcSEcCtD
Cetrorelix—Menopausal symptoms—Paclitaxel—kidney cancer	0.00517	0.0102	CcSEcCtD
Cetrorelix—Erythema—Erlotinib—kidney cancer	0.00505	0.00994	CcSEcCtD
Cetrorelix—Immune system disorder—Sorafenib—kidney cancer	0.00472	0.00928	CcSEcCtD
Cetrorelix—Cough—Everolimus—kidney cancer	0.00457	0.00899	CcSEcCtD
Cetrorelix—Erythema—Sorafenib—kidney cancer	0.00454	0.00894	CcSEcCtD
Cetrorelix—Swelling—Capecitabine—kidney cancer	0.00454	0.00893	CcSEcCtD
Cetrorelix—Immune system disorder—Sunitinib—kidney cancer	0.00454	0.00893	CcSEcCtD
Cetrorelix—Cough—Erlotinib—kidney cancer	0.00441	0.00867	CcSEcCtD
Cetrorelix—Erythema—Sunitinib—kidney cancer	0.00437	0.00861	CcSEcCtD
Cetrorelix—Hot flush—Capecitabine—kidney cancer	0.00428	0.00842	CcSEcCtD
Cetrorelix—Menopausal symptoms—Capecitabine—kidney cancer	0.00424	0.00835	CcSEcCtD
Cetrorelix—Hypersensitivity—Temsirolimus—kidney cancer	0.00423	0.00833	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—OR4C13—kidney cancer	0.00419	0.0207	CbGpPWpGaD
Cetrorelix—Erythema—Dactinomycin—kidney cancer	0.00414	0.00815	CcSEcCtD
Cetrorelix—Pruritus—Temsirolimus—kidney cancer	0.00406	0.008	CcSEcCtD
Cetrorelix—Hypotension—Everolimus—kidney cancer	0.00399	0.00786	CcSEcCtD
Cetrorelix—Cough—Sorafenib—kidney cancer	0.00397	0.0078	CcSEcCtD
Cetrorelix—Pruritus—Pazopanib—kidney cancer	0.00383	0.00753	CcSEcCtD
Cetrorelix—Cough—Sunitinib—kidney cancer	0.00382	0.00751	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—OR4C13—kidney cancer	0.00381	0.0188	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Sorafenib—kidney cancer	0.00371	0.0073	CcSEcCtD
Cetrorelix—Immune system disorder—Gemcitabine—kidney cancer	0.00364	0.00716	CcSEcCtD
Cetrorelix—Rash—Temsirolimus—kidney cancer	0.00362	0.00713	CcSEcCtD
Cetrorelix—Dermatitis—Temsirolimus—kidney cancer	0.00362	0.00712	CcSEcCtD
Cetrorelix—Headache—Temsirolimus—kidney cancer	0.0036	0.00708	CcSEcCtD
Cetrorelix—Injection site reaction—Doxorubicin—kidney cancer	0.00353	0.00695	CcSEcCtD
Cetrorelix—Erythema—Gemcitabine—kidney cancer	0.00351	0.0069	CcSEcCtD
Cetrorelix—GNRHR—G alpha (q) signalling events—ITPR2—kidney cancer	0.00348	0.0172	CbGpPWpGaD
Cetrorelix—Rash—Pazopanib—kidney cancer	0.00341	0.00671	CcSEcCtD
Cetrorelix—Nausea—Temsirolimus—kidney cancer	0.00341	0.00671	CcSEcCtD
Cetrorelix—Dermatitis—Pazopanib—kidney cancer	0.00341	0.00671	CcSEcCtD
Cetrorelix—Headache—Pazopanib—kidney cancer	0.00339	0.00667	CcSEcCtD
Cetrorelix—Nausea—Pazopanib—kidney cancer	0.00321	0.00633	CcSEcCtD
Cetrorelix—Hypersensitivity—Vinblastine—kidney cancer	0.00316	0.00622	CcSEcCtD
Cetrorelix—Hypersensitivity—Everolimus—kidney cancer	0.00315	0.00619	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.00311	0.0154	CbGpPWpGaD
Cetrorelix—Cough—Gemcitabine—kidney cancer	0.00306	0.00603	CcSEcCtD
Cetrorelix—Immune system disorder—Paclitaxel—kidney cancer	0.00305	0.006	CcSEcCtD
Cetrorelix—Pruritus—Everolimus—kidney cancer	0.00302	0.00595	CcSEcCtD
Cetrorelix—Anaphylactic shock—Vincristine—kidney cancer	0.00302	0.00594	CcSEcCtD
Cetrorelix—LHCGR—G alpha (s) signalling events—POMC—kidney cancer	0.00296	0.0146	CbGpPWpGaD
Cetrorelix—Erythema—Paclitaxel—kidney cancer	0.00294	0.00578	CcSEcCtD
Cetrorelix—Pruritus—Erlotinib—kidney cancer	0.00292	0.00574	CcSEcCtD
Cetrorelix—GNRHR—G alpha (q) signalling events—ANXA1—kidney cancer	0.00291	0.0144	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00288	0.0142	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Gemcitabine—kidney cancer	0.00286	0.00564	CcSEcCtD
Cetrorelix—Hypotension—Vincristine—kidney cancer	0.00282	0.00555	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—OR4C13—kidney cancer	0.00281	0.0139	CbGpPWpGaD
Cetrorelix—Hot flush—Doxorubicin—kidney cancer	0.00276	0.00543	CcSEcCtD
Cetrorelix—Menopausal symptoms—Doxorubicin—kidney cancer	0.00273	0.00538	CcSEcCtD
Cetrorelix—Hypersensitivity—Sorafenib—kidney cancer	0.00273	0.00538	CcSEcCtD
Cetrorelix—Rash—Everolimus—kidney cancer	0.00269	0.0053	CcSEcCtD
Cetrorelix—Dermatitis—Everolimus—kidney cancer	0.00269	0.0053	CcSEcCtD
Cetrorelix—Headache—Vinblastine—kidney cancer	0.00269	0.00529	CcSEcCtD
Cetrorelix—Headache—Everolimus—kidney cancer	0.00268	0.00527	CcSEcCtD
Cetrorelix—Hypotension—Gemcitabine—kidney cancer	0.00268	0.00527	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00267	0.00525	CcSEcCtD
Cetrorelix—Hypersensitivity—Sunitinib—kidney cancer	0.00263	0.00517	CcSEcCtD
Cetrorelix—Pruritus—Sorafenib—kidney cancer	0.00262	0.00516	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.00261	0.0129	CbGpPWpGaD
Cetrorelix—Rash—Erlotinib—kidney cancer	0.0026	0.00512	CcSEcCtD
Cetrorelix—Dermatitis—Erlotinib—kidney cancer	0.0026	0.00511	CcSEcCtD
Cetrorelix—Headache—Erlotinib—kidney cancer	0.00258	0.00508	CcSEcCtD
Cetrorelix—Cough—Paclitaxel—kidney cancer	0.00256	0.00504	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—OR4C13—kidney cancer	0.00255	0.0126	CbGpPWpGaD
Cetrorelix—Nausea—Vinblastine—kidney cancer	0.00255	0.00501	CcSEcCtD
Cetrorelix—Nausea—Everolimus—kidney cancer	0.00254	0.00499	CcSEcCtD
Cetrorelix—Pruritus—Sunitinib—kidney cancer	0.00252	0.00497	CcSEcCtD
Cetrorelix—Immune system disorder—Capecitabine—kidney cancer	0.0025	0.00492	CcSEcCtD
Cetrorelix—Hypersensitivity—Dactinomycin—kidney cancer	0.00249	0.0049	CcSEcCtD
Cetrorelix—Nausea—Erlotinib—kidney cancer	0.00245	0.00482	CcSEcCtD
Cetrorelix—Erythema—Capecitabine—kidney cancer	0.00241	0.00474	CcSEcCtD
Cetrorelix—Anaphylactic shock—Paclitaxel—kidney cancer	0.0024	0.00472	CcSEcCtD
Cetrorelix—Rash—Sorafenib—kidney cancer	0.00234	0.0046	CcSEcCtD
Cetrorelix—Dermatitis—Sorafenib—kidney cancer	0.00234	0.0046	CcSEcCtD
Cetrorelix—Headache—Sorafenib—kidney cancer	0.00232	0.00457	CcSEcCtD
Cetrorelix—Rash—Sunitinib—kidney cancer	0.00225	0.00443	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—OR4C13—kidney cancer	0.00225	0.0111	CbGpPWpGaD
Cetrorelix—Dermatitis—Sunitinib—kidney cancer	0.00225	0.00442	CcSEcCtD
Cetrorelix—Hypotension—Paclitaxel—kidney cancer	0.00224	0.00441	CcSEcCtD
Cetrorelix—Headache—Sunitinib—kidney cancer	0.00224	0.0044	CcSEcCtD
Cetrorelix—Hypersensitivity—Vincristine—kidney cancer	0.00222	0.00438	CcSEcCtD
Cetrorelix—Nausea—Sorafenib—kidney cancer	0.0022	0.00434	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—ANXA1—kidney cancer	0.00219	0.0108	CbGpPWpGaD
Cetrorelix—Rash—Dactinomycin—kidney cancer	0.00213	0.00419	CcSEcCtD
Cetrorelix—Nausea—Sunitinib—kidney cancer	0.00212	0.00417	CcSEcCtD
Cetrorelix—Cough—Capecitabine—kidney cancer	0.0021	0.00414	CcSEcCtD
Cetrorelix—Pruritus—Gemcitabine—kidney cancer	0.00203	0.00399	CcSEcCtD
Cetrorelix—Nausea—Dactinomycin—kidney cancer	0.00201	0.00395	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.00193	0.00954	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LATS1—kidney cancer	0.00191	0.00945	CbGpPWpGaD
Cetrorelix—Rash—Vincristine—kidney cancer	0.0019	0.00375	CcSEcCtD
Cetrorelix—Dermatitis—Vincristine—kidney cancer	0.0019	0.00374	CcSEcCtD
Cetrorelix—Headache—Vincristine—kidney cancer	0.00189	0.00372	CcSEcCtD
Cetrorelix—Hypotension—Capecitabine—kidney cancer	0.00184	0.00362	CcSEcCtD
Cetrorelix—Rash—Gemcitabine—kidney cancer	0.00181	0.00355	CcSEcCtD
Cetrorelix—Dermatitis—Gemcitabine—kidney cancer	0.0018	0.00355	CcSEcCtD
Cetrorelix—Headache—Gemcitabine—kidney cancer	0.00179	0.00353	CcSEcCtD
Cetrorelix—Nausea—Vincristine—kidney cancer	0.00179	0.00353	CcSEcCtD
Cetrorelix—Hypersensitivity—Paclitaxel—kidney cancer	0.00177	0.00348	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—AKAP13—kidney cancer	0.00174	0.0086	CbGpPWpGaD
Cetrorelix—Nausea—Gemcitabine—kidney cancer	0.0017	0.00335	CcSEcCtD
Cetrorelix—Pruritus—Paclitaxel—kidney cancer	0.0017	0.00334	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—AMER1—kidney cancer	0.00163	0.00803	CbGpPWpGaD
Cetrorelix—Immune system disorder—Doxorubicin—kidney cancer	0.00161	0.00317	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—AKAP13—kidney cancer	0.00158	0.00781	CbGpPWpGaD
Cetrorelix—Erythema—Doxorubicin—kidney cancer	0.00155	0.00306	CcSEcCtD
Cetrorelix—Rash—Paclitaxel—kidney cancer	0.00151	0.00297	CcSEcCtD
Cetrorelix—Dermatitis—Paclitaxel—kidney cancer	0.00151	0.00297	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—OR4C13—kidney cancer	0.00151	0.00744	CbGpPWpGaD
Cetrorelix—Headache—Paclitaxel—kidney cancer	0.0015	0.00296	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—ITPR2—kidney cancer	0.00148	0.00731	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—ANXA1—kidney cancer	0.00147	0.00726	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Capecitabine—kidney cancer	0.00145	0.00285	CcSEcCtD
Cetrorelix—Nausea—Paclitaxel—kidney cancer	0.00142	0.0028	CcSEcCtD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00141	0.00698	CbGpPWpGaD
Cetrorelix—Pruritus—Capecitabine—kidney cancer	0.00139	0.00274	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GPC3—kidney cancer	0.00136	0.00673	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CER1—kidney cancer	0.00136	0.00673	CbGpPWpGaD
Cetrorelix—Cough—Doxorubicin—kidney cancer	0.00136	0.00267	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—ITPR2—kidney cancer	0.00134	0.00664	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LATS1—kidney cancer	0.00128	0.00633	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Doxorubicin—kidney cancer	0.00127	0.0025	CcSEcCtD
Cetrorelix—Rash—Capecitabine—kidney cancer	0.00124	0.00244	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—ANXA1—kidney cancer	0.00124	0.00613	CbGpPWpGaD
Cetrorelix—Dermatitis—Capecitabine—kidney cancer	0.00124	0.00244	CcSEcCtD
Cetrorelix—Headache—Capecitabine—kidney cancer	0.00123	0.00243	CcSEcCtD
Cetrorelix—Hypotension—Doxorubicin—kidney cancer	0.00119	0.00233	CcSEcCtD
Cetrorelix—Nausea—Capecitabine—kidney cancer	0.00117	0.0023	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—AKAP13—kidney cancer	0.00117	0.00576	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SFRP2—kidney cancer	0.00116	0.00573	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ANXA1—kidney cancer	0.00113	0.00557	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AMER1—kidney cancer	0.00109	0.00538	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—POMC—kidney cancer	0.00108	0.00531	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKAP13—kidney cancer	0.00106	0.00523	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.00105	0.0052	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ITPR2—kidney cancer	0.000991	0.0049	CbGpPWpGaD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000945	0.00467	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Doxorubicin—kidney cancer	0.000934	0.00184	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—AKAP13—kidney cancer	0.000934	0.00461	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP2—kidney cancer	0.000934	0.00461	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GPC3—kidney cancer	0.000912	0.00451	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CER1—kidney cancer	0.000912	0.00451	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ITPR2—kidney cancer	0.0009	0.00445	CbGpPWpGaD
Cetrorelix—Pruritus—Doxorubicin—kidney cancer	0.000897	0.00177	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GRB7—kidney cancer	0.000854	0.00422	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ANXA1—kidney cancer	0.00083	0.0041	CbGpPWpGaD
Cetrorelix—Rash—Doxorubicin—kidney cancer	0.0008	0.00157	CcSEcCtD
Cetrorelix—Dermatitis—Doxorubicin—kidney cancer	0.000799	0.00157	CcSEcCtD
Cetrorelix—Headache—Doxorubicin—kidney cancer	0.000794	0.00156	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—ITPR2—kidney cancer	0.000794	0.00392	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SFRP2—kidney cancer	0.000776	0.00383	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000759	0.00375	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ANXA1—kidney cancer	0.000754	0.00373	CbGpPWpGaD
Cetrorelix—Nausea—Doxorubicin—kidney cancer	0.000753	0.00148	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000722	0.00357	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CTNNA1—kidney cancer	0.00072	0.00356	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—POMC—kidney cancer	0.00072	0.00356	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000716	0.00354	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HSPB1—kidney cancer	0.000716	0.00354	CbGpPWpGaD
Cetrorelix—GNRHR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.0007	0.00346	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000682	0.00337	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ANXA1—kidney cancer	0.000665	0.00329	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TSC1—kidney cancer	0.000665	0.00329	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PSMD7—kidney cancer	0.000665	0.00329	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FLT1—kidney cancer	0.000644	0.00318	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000626	0.0031	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP2—kidney cancer	0.000625	0.00309	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKAP13—kidney cancer	0.000625	0.00309	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—POMC—kidney cancer	0.000608	0.003	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—JUNB—kidney cancer	0.000597	0.00295	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PAK1—kidney cancer	0.000597	0.00295	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRB7—kidney cancer	0.000572	0.00283	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—POMC—kidney cancer	0.000552	0.00273	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ITPR2—kidney cancer	0.000532	0.00263	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF2—kidney cancer	0.000488	0.00241	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN2B—kidney cancer	0.000486	0.0024	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CTNNA1—kidney cancer	0.000482	0.00238	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000479	0.00237	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HSPB1—kidney cancer	0.000479	0.00237	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1R—kidney cancer	0.000472	0.00233	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—RAF1—kidney cancer	0.000455	0.00225	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—IL2—kidney cancer	0.000449	0.00222	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TSC1—kidney cancer	0.000445	0.0022	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PSMD7—kidney cancer	0.000445	0.0022	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ANXA1—kidney cancer	0.000445	0.0022	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FLT1—kidney cancer	0.000431	0.00213	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL2—kidney cancer	0.000408	0.00202	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—POMC—kidney cancer	0.000407	0.00201	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PAK1—kidney cancer	0.0004	0.00198	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUNB—kidney cancer	0.0004	0.00198	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIF1A—kidney cancer	0.000389	0.00192	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TSC2—kidney cancer	0.000388	0.00192	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KDR—kidney cancer	0.000372	0.00184	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—POMC—kidney cancer	0.000369	0.00183	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APC—kidney cancer	0.000342	0.00169	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KIT—kidney cancer	0.000342	0.00169	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—MAPK3—kidney cancer	0.000328	0.00162	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF2—kidney cancer	0.000327	0.00162	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—POMC—kidney cancer	0.000326	0.00161	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN2B—kidney cancer	0.000325	0.00161	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—BRAF—kidney cancer	0.000322	0.00159	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1R—kidney cancer	0.000316	0.00156	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—MAPK1—kidney cancer	0.000312	0.00154	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—RAF1—kidney cancer	0.000305	0.00151	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—IL2—kidney cancer	0.000301	0.00149	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CA—kidney cancer	0.000298	0.00147	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—KRAS—kidney cancer	0.000295	0.00146	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL2—kidney cancer	0.000273	0.00135	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CA—kidney cancer	0.000271	0.00134	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RAF1—kidney cancer	0.000269	0.00133	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RELA—kidney cancer	0.000268	0.00132	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB2—kidney cancer	0.000266	0.00131	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MTOR—kidney cancer	0.000262	0.0013	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIF1A—kidney cancer	0.00026	0.00129	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TSC2—kidney cancer	0.00026	0.00128	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KDR—kidney cancer	0.000249	0.00123	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1B—kidney cancer	0.000246	0.00122	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL2—kidney cancer	0.000241	0.00119	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CCND1—kidney cancer	0.000235	0.00116	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—JUN—kidney cancer	0.000234	0.00116	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CTNNB1—kidney cancer	0.000233	0.00115	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APC—kidney cancer	0.000229	0.00113	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KIT—kidney cancer	0.000229	0.00113	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTEN—kidney cancer	0.000227	0.00112	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAPK3—kidney cancer	0.00022	0.00109	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—POMC—kidney cancer	0.000218	0.00108	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—BRAF—kidney cancer	0.000215	0.00106	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAPK1—kidney cancer	0.000209	0.00103	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFA—kidney cancer	0.000205	0.00101	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CA—kidney cancer	0.0002	0.000987	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—KRAS—kidney cancer	0.000197	0.000975	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAPK3—kidney cancer	0.000194	0.000957	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MYC—kidney cancer	0.000188	0.000931	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAPK1—kidney cancer	0.000184	0.000911	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CA—kidney cancer	0.000181	0.000896	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RAF1—kidney cancer	0.00018	0.000889	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RELA—kidney cancer	0.000179	0.000885	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB2—kidney cancer	0.000178	0.00088	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MTOR—kidney cancer	0.000176	0.000868	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KRAS—kidney cancer	0.000174	0.00086	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1B—kidney cancer	0.000165	0.000815	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL2—kidney cancer	0.000161	0.000797	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CA—kidney cancer	0.00016	0.000791	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CCND1—kidney cancer	0.000157	0.000777	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUN—kidney cancer	0.000157	0.000776	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CTNNB1—kidney cancer	0.000156	0.00077	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—kidney cancer	0.000155	0.000765	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTEN—kidney cancer	0.000152	0.00075	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFA—kidney cancer	0.000137	0.000678	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAPK3—kidney cancer	0.00013	0.000641	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MYC—kidney cancer	0.000126	0.000623	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAPK1—kidney cancer	0.000123	0.00061	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KRAS—kidney cancer	0.000117	0.000576	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CA—kidney cancer	0.000107	0.000529	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—kidney cancer	0.000104	0.000512	CbGpPWpGaD
